YOLFTbeta
00

Lanzhou Foci Pharmaceutical Co Ltd

002644 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

7.34CNY-0.17 (-2.26%)

Price History

Full chart

Market Stats

Previous Close7.51
Open7.51
Day Range7.32 – 7.51
52-Week Range6.63 – 10.99
Volume3.64M
Market Cap4.22B
P/E (TTM)75.09
Forward P/E0.00
EPS0.11
Dividend Yield0.24%
Beta0.20
50-Day Avg8.24
200-Day Avg8.34

About

LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional Chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; pre-packaged food; processing and selling of Chinese herbal medicine pieces; technology development, and professional and technical services; inspection and testing services; and production and sales of medical devices. The company exports its products. LanZhou Foci Pharmaceutical Co.,Ltd. was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of Lanzhou Foci pharmaceutical industry development Group co., ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Shuangxi Qian
  • Employees1.33K
  • HeadquartersNo. 2289 Huashan Road, Lanzhou, China, 730000, China
  • Websitehttps://www.fczy.com

Leadership

  • Mr. Shuangxi QianGM & Director · b. 1985
  • Ms. Jinfeng YueChief Financial Officer · b. 1977
  • Mr. Guo Lin ChaiDeputy General Manager · b. 1967
  • Mr. Xiao Yun FengDeputy General Manager · b. 1969
  • Mr. Junhui WangSecretary of the Board · b. 1984
  • Mr. Yingming ZhangDeputy General Manager · b. 1973
  • Ling WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue177.49M219.01M232.21M262.41M271.18M266.36M291.53M399.07M327.58M363.26M501.14M544.58M628.82M668.05M817.64M1.04B1.16B980.23M915.53M
Growth (%)-+23.39%+6.03%+13.00%+3.35%-1.78%+9.45%+36.89%-17.91%+10.89%+37.96%+8.67%+15.47%+6.24%+22.39%+27.49%+11.58%-15.73%-6.60%
Cost of Revenue104.86M131.81M144.17M167.48M177.99M179.85M188.27M312.01M245.61M255.24M353.27M368.84M455.51M503.63M596.57M738.23M804.17M681.46M603.42M
Gross Profit72.63M87.20M88.04M94.93M93.19M86.51M103.26M87.06M81.98M108.01M147.87M175.74M173.30M164.42M221.07M304.16M358.96M298.76M312.12M
Gross Margin40.92%39.82%37.91%36.17%34.37%32.48%35.42%21.82%25.02%29.73%29.51%32.27%27.56%24.61%27.04%29.18%30.86%30.48%34.09%
Operating Expense44.93M62.25M60.97M63.26M61.66M56.19M77.02M58.62M40.51M43.33M62.65M88.02M90.34M34.08M108.71M161.01M275.69M228.32M186.19M
Operating Income27.70M24.95M27.07M31.66M31.53M30.31M26.24M28.44M41.47M64.68M85.22M87.72M82.96M130.34M112.36M143.14M83.27M70.45M125.93M
Operating Margin15.61%11.39%11.66%12.07%11.63%11.38%9.00%7.13%12.66%17.81%17.00%16.11%13.19%19.51%13.74%13.73%7.16%7.19%13.75%
EBITDA37.36M43.83M43.17M70.55M51.20M53.53M56.81M58.12M67.97M89.12M109.99M122.89M137.68M176.94M159.68M181.62M134.51M119.66M121.10M
EBITDA Margin21.05%20.01%18.59%26.89%18.88%20.10%19.49%14.56%20.75%24.53%21.95%22.57%21.89%26.49%19.53%17.42%11.56%12.21%13.23%
Net Income23.31M21.61M36.15M51.24M32.06M30.36M30.60M34.65M42.95M60.93M74.09M74.28M74.85M108.02M93.26M108.65M67.19M60.07M49.21M
Net Income Margin13.13%9.87%15.57%19.53%11.82%11.40%10.50%8.68%13.11%16.77%14.78%13.64%11.90%16.17%11.41%10.42%5.78%6.13%5.37%
R&D-2.52M3.31M4.50M7.46M9.89M10.90M10.10M10.01M13.49M17.26M19.52M20.65M15.38M19.36M23.56M30.93M29.28M24.56M
R&D as % of Total Revenue-1.15%1.43%1.72%2.75%3.71%3.74%2.53%3.06%3.71%3.44%3.58%3.28%2.30%2.37%2.26%2.66%2.99%2.68%
Interest Expense3.00M4.23M2.56M3.61M4.29M4.94M5.85M3.60M986.31K3611.60M642.00K1.12M1.39M1.05M2.04M1.47M887.67K770.72K
Interest Expense % of Total Revenue1.69%1.93%1.10%1.38%1.58%1.85%2.01%0.90%0.30%0.00%0.32%0.12%0.18%0.21%0.13%0.20%0.13%0.09%0.08%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets359.92M400.52M422.05M456.16M829.23M822.91M903.08M1.05B1.36B2.04B2.35B2.52B2.40B2.39B2.35B2.59B2.53B2.47B2.55B
Total Liabilities164.72M183.70M169.09M129.70M181.14M147.38M199.70M311.40M128.77M746.13M990.68M1.08B893.78M800.08M724.59M852.60M759.67M654.81M692.03M
Total Equity195.20M216.81M252.96M326.46M648.08M675.53M703.37M735.22M1.23B1.29B1.36B1.44B1.50B1.58B1.61B1.72B1.75B1.79B1.83B
Cash6.59M9.26M18.74M67.79M325.47M190.00M161.84M275.65M498.98M418.56M70.20M465.55M434.65M419.96M374.94M396.45M406.04M397.89M524.49M
Total Debt49.00M61.00M48.00M48.00M78.00M78.00M124.00M26.00M5.16M108.11M109.39M17.25M14.52M33.98M15.51M14.37M11.35M12.85M-
Net Debt42.41M51.74M29.26M-19.79M-247.47M-112.00M-37.84M-249.65M-493.82M-310.45M39.19M-448.30M-420.13M-385.98M-359.43M-382.08M-380.01M-385.04M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow105.61M602.56K3.46M56.18M2.43M-11.02M-10.47M93.75M64.11M56.90M66.42M36.66M47.82M62.89M11.85M72.37M65.71M38.98M183.95M
Investing Cash Flow-105.34M-5.86M23.34M-6.00M-69.90M-113.77M-85.71M124.45M-47.37M229.30M-442.77M-292.13M-58.04M-61.89M42.65M-42.85M-34.16M-11.72M-
Financing Cash Flow-3.90M8.04M-17.29M-997.81K325.26M-10.74M67.79M-104.39M428.04M87.31M-3.84M6.67M-20.60M-23.55M-93.41M-15.45M-25.00M-29.00M-
Capital Expenditure107.55M6.39M23.27M21.86M69.92M113.77M85.81M48.36M51.92M267.00M442.77M261.12M93.15M122.58M32.81M41.51M22.47M13.29M18.55M
Free Cash Flow-1.95M-5.79M-19.81M34.32M-67.50M-124.79M-96.29M45.39M12.20M-210.10M-376.35M-224.46M-45.33M-59.69M-20.95M30.86M43.24M25.70M165.40M
Dividends Paid2.65M3.96M2.54M2.50M4.14M7.80M8.60M6.39M4.15M4.60M6.13M6.64M6.64M30.64M61.28M5.11M27.94M15.96M7.02M
FCF to OCF-1.84%-960.42%-571.66%61.10%-2782.18%1132.74%919.26%48.42%19.02%-369.24%-566.59%-612.21%-94.78%-94.91%-176.73%42.64%65.80%65.91%89.92%
Dividend Paid to FCF-136.03%-68.41%-12.82%7.28%-6.13%-6.25%-8.93%14.08%34.00%-2.19%-1.63%-2.96%-14.65%-51.33%-292.49%16.55%64.63%62.09%4.25%

Earnings

Report DateDec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 28, 2014Dec 31, 2014Apr 9, 2015Jul 16, 2015Oct 15, 2015Feb 24, 2016Apr 22, 2016Jul 15, 2016Oct 25, 2016Jan 10, 2017Apr 20, 2017Jul 25, 2017Oct 20, 2017Jan 25, 2018Apr 24, 2018Jul 27, 2018Oct 23, 2018Mar 21, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 27, 2020Oct 21, 2020Mar 25, 2021Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 11, 2024Apr 30, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Apr 30, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------0.05-0.060.06-----0.060.060.06------------------------------------
EPS Actual0.040.010.020.020.020.010.020.020.010.010.020.030.020.020.030.030.020.020.040.030.030.030.030.030.040.040.040.030.030.030.060.060.000.030.170.020.010.050.050.050.040.040.060.000.100.050.060.000.020.040.030.010.040.040.020.020.020.040.03
Surprise------------40.00%--66.67%-50.00%------50.00%-50.00%-50.00%------------------------------------
Timing-----------Pre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.22B
Enterprise Value3.57B
Trailing P/E75.09
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.55
Price / Book2.24
EPS0.11
Book Value3.65
Revenue (TTM)926.49M
Gross Profit (TTM)309.38M
EBITDA113.65M
Profit Margin6.35%
Operating Margin5.74%
Return on Equity2.95%
Return on Assets1.34%
Shares Outstanding510.66M
Shares Float189.17M
Beta0.20
Dividend Yield0.24%
Dividend Rate0.02
Payout Ratio17.36%

Dividends

20262×
0.06Oct 22, 20260.02Jun 26, 2026
20251×
0.01Jun 24, 2025
20241×
0.03Jun 25, 2024
20231×
0.05Jun 15, 2023
20221×
0.01May 27, 2022
20211×
0.12Jul 9, 2021
20201×
0.06Jun 12, 2020
20191×
0.01Jun 5, 2019
20181×
0.01Apr 26, 2018
20171×
0.01Jun 9, 2017
20161×
0.01Jun 7, 2016
20151×
0.01Jun 24, 2015
20141×
0.01May 21, 2014
20131×
0.01Jun 21, 2013
20121×
0.01Jun 6, 2012

Stock Splits

  • Aug 14, 201525:10
  • May 21, 201420:10
  • Jun 6, 201211:10